491
|
|
|
Neuropeptide VF precursor |
C7orf9, RFRP |
|
492
|
|
|
Neuropeptide Y |
PYY4 |
Alzheimer disease, Anorexia, Anxiety disorder, Arteriosclerosis, Asthma, Autism, Bronchitis, Cardiovascular disease, Ischemic stroke, Childhood absence epilepsy, Depression, Colorectal adenoma, Major depressive disorder, Diabetes mellitus type 2, Eating disorder, Epilepsy, Atypical absence epilepsy, Minor epilepsy, Temporal lobe epilepsy, Huntington disease, Hyperkinesia, Hypertension, Hypertrophy, Memory disorders, Metabolic syndrome, Mood disorder, Nasal obstruction, Non-neoplastic peripheral nervous system disease, Periodontitis, Peripheral nervous system disease, Peripheral neuropathy, Rhinitis, Schizoaffective disorder, Schizophrenia, Scoliosis, Seasonal affective disorder, Seizures, Substance abuseView all (23 more) |
493
|
|
|
Neuropeptide Y receptor Y1 |
NPY1-R, NPYR |
Amphetamine or sympathomimetic abuse, Anxiety disorder, Major depressive disorder, Glioma, Lung cancer, Neural tube defect, Neural tube defects, x-linked, Non-organic psychosis, Obesity, Substance-induced psychosis, Psychotic disorders, Schizophrenia, Squamous cell carcinoma |
494
|
|
|
Neuropeptide Y receptor Y2 |
NPY2-R |
|
495
|
|
|
Neuropeptide Y receptor Y5 |
NPY5-R, NPYR5, NPYY5-R |
|
496
|
|
|
NAD(P)H quinone dehydrogenase 1 |
DHQU, DIA4, DTD, NMOR1, NMORI, QR1 |
Asthma, Atherosclerosis, Autism, Breast neoplasms, Non-small-cell lung carcinoma, Cholelithiasis, Obstructive airway disease, Colorectal neoplasms, Contact dermatitis, Hemolytic uremic syndrome, Hemorrhage, Hyperglycemia, Hypertension, Kidney disease, Kidney failure, Myeloid leukemia, Liver disease, Lung disease, Macular degeneration, Multiple myeloma, Nonalcoholic fatty liver disease, Obesity, Occupational disease, Papilloma, Parkinson disease, Prostatic neoplasms, Spinocerebellar ataxia, Diabetes mellitus type 2, Urinary bladder neoplasms, Warfarin sensitivityView all (15 more) |
497
|
|
|
N-ribosyldihydronicotinamide:quinone dehydrogenase 2 |
DHQV, DIA6, NMOR2, QR2 |
Autism, Bone marrow diseases, Breast neoplasms, Contact dermatitis, Alzheimer disease, Breast cancer, Hereditary breast cancer, Memory disorders, Non-organic psychosis, Parkinson disease, Psychotic disorders, Schizophrenia |
498
|
|
|
Nuclear receptor subfamily 0 group B member 1 |
AHC, AHCH, AHX, DAX-1, DAX1, DSS, GTD, HHG, NROB1, SRXY2 |
|
499
|
|
|
Nuclear receptor subfamily 0 group B member 2 |
SHP, SHP1 |
Hepatocellular carcinoma, Cognition disorder, Diabetes complications, Delirium, dementia, and cognitive disorders, Diabetes mellitus type 2, Fatty liver, Fatty liver, alcoholic, Lipidoses, Lipoidosis, Obesity, Schizophrenia |
500
|
|
|
Nuclear receptor subfamily 1 group D member 1 |
EAR1, REVERBA, REVERBalpha, THRA1, THRAL, ear-1, hRev |
Asthma, Bipolar disorder, Central nervous system cancer, Major depressive disorder, Fatty liver, Fatty liver, alcoholic, Glioblastoma, Glioma, Multiple sclerosis, Peptic ulcer disease, Seasonal affective disorder |
